Evidence map›Paper›PMID 38698101›Full record

GuidelineArchives of osteoporosis2024

Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar.

Fiaz Alam, Omar Alsaed, Nabeel Abdulla, Ibrahim Abdulmomen, Abdo Lutf, Samar Al Emadi

Abstract readPractice Guideline
In one paragraph

Guideline in Archives of osteoporosis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fiaz AlamRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar. Fiaz.alam@yahoo.com.ORCID 0000-0002-0243-0202
Omar AlsaedRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-6103-2896
Nabeel AbdullaRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-7787-8717
Ibrahim AbdulmomenRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0003-0023-6104
Abdo LutfRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0003-1957-9625
Samar Al EmadiRheumatology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-7942-4831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present comprehensive guidelines for osteoporosis management in Qatar. Formulated by the Qatar Osteoporosis Association, the guidelines recommend the age-dependent Qatar fracture risk assessment tool for screening, emphasizing risk-based treatment strategies and discouraging routine dual-energy X-ray scans. They offer a vital resource for physicians managing osteoporosis and fragility fractures nationwide. PURPOSE: Osteoporosis and related fragility fractures are a growing public health issue with an impact on individuals and the healthcare system. We aimed to present guidelines providing unified guidance to all healthcare professionals in Qatar regarding the management of osteoporosis.

methodsThe Qatar Osteoporosis Association formulated guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men above the age of 50. A panel of six local rheumatologists who are experts in the field of osteoporosis met together and conducted an extensive review of published articles and local and international guidelines to formulate guidance for the screening and management of postmenopausal women and men older than 50 years in Qatar.

resultsThe guidelines emphasize the use of the age-dependent hybrid model of the Qatar fracture risk assessment tool for screening osteoporosis and risk categorization. The guidelines include screening, risk stratification, investigations, treatment, and monitoring of patients with osteoporosis. The use of a dual-energy X-ray absorptiometry scan without any risk factors is discouraged. Treatment options are recommended based on risk stratification.

conclusionGuidance is provided to all physicians across the country who are involved in the care of patients with osteoporosis and fragility fractures.

Indexed as

Osteoporotic FracturesAbsorptiometry, PhotonAgedBone DensityBone Density Conservation AgentsFemaleHumansMaleMiddle AgedOsteoporosisOsteoporosis, PostmenopausalQatarRisk AssessmentBone Density Conservation AgentsFracture risk assessment toolFragility fracturesFRAXGuidelinesOsteoporosis

Identifiers

PMID38698101
PMCPMC11065783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.